依西美坦+依维莫司治疗乳腺癌并发酮症酸中毒急性胰腺炎及脑出血一例

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：vingf

【摘要】

：

目的：为更好的使用依维莫司治疗乳腺癌提供安全有效的参考。方法：以依西美坦+依维莫司治疗乳腺癌1例的治疗过程,报道本方案的有效性、安全性和注意的并发症。结果：无患者女50岁已婚于2012-12-05行左乳腺癌改良根治术,术后病理示左乳导管内癌,局部浸润肿物直径3cm,腋下淋巴结(2/2)、左腋窝淋巴结(1/4)见癌转移,免疫组化示ER(60％+)、PR(50％+)、Her-2(+/-)。

【作者】

：

张凤春徐海燕张琳陈彬汪娟杨懿谨周晔明陈熙昀

【机构】

：

苏州上海交通大学医学院苏州九龙医院肿瘤科上海交通大学医学院附属瑞金医院肿瘤学科肿瘤科苏州上海

【出处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年4期

【关键词】

：

依西美坦+依维莫司乳腺癌并发症

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Overexpression of RHOC predicts poor patient prognosis and promotes cell invasion in human cholangio

Objective: RHOC, as a member of the Ras superfamily of GTP-binding proteins, has been demonstrated to be involved in metastasis of many human malignancies;however, its role in human cholangiocellular

会议

humancholangiocellular carcinoma (CCC)RHOC invasion

PRMT5 protects pancreatic cancer cells from apoptosis under hypoxia conditions via down-regulation o

Objective: Pancreatic cancer is one of the most intractable and fatal cancer and biologically characterized by high degrees of hypoxia.Here, we describe PRMT5 (protein arginine methltransferase 5), a

会议

Pancreatic cancerPRMT5cancer metabolism

Preoperative Serum Fibrinogen is an Independent Prognostic Factor in Operable Esophageal Cancer

Objective: Increased serum fibrinogen has been reported to be associated with tumor progression and a poor outcome in various carcinomas.However, the association between preoperative serum fibrinogen

会议

fibrinogenesophagealcanceroverallsurvival

髓源抑制性细胞与结肠癌临床病理特征关系的研究

目的：探讨结肠癌肿瘤组织中MDSCs与肿瘤生长和演进中病理特征相关性研究，对于以MDSCs为靶点的胃肠道肿瘤的治疗具有重要意义。方法：收集10名健康志愿者(年龄30-50岁，平均年龄39岁)的正常结肠粘膜和45名新诊断的结肠癌患者(年龄35-80岁，平均年龄58岁)的肿瘤组织，用荧光标记的抗人Lin1、HLA DR、CD33及CD11b单克隆抗体标记肿瘤患者肿瘤组织和健康人的正常结肠粘膜，应用激光

会议

髓源抑制性细胞结肠恶性肿瘤

Preclinical evaluation of AMG 337, a highly selective small molecule MET inhibitor, in hepatocellula

Objective: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide.Aberrant hepatocyte growth factor/MET signaling has been implicated in hepatocarcinogenesis, sug

会议

MET

Safety and activity of blinatumomab for older patients (pts)with relapsed/refractory (R/R) B precurs

Objective: Treatment options for older pts with R/R ALL are limited.Blinatumomab is a bispecific T-cell engager(BiTE(R)) antibody construct that directs cytotoxic T cells to CD 19-expressing B cells,

会议

blinatumomabolder patientsB precursor acute lymp

Transcriptome sequencing Reveals the Potential Roles of driven genes in Chemotherapy-induced multidr

目的： Lung cancer is the leading cause of cancer-related deaths in China, currently, lun adenocarcinoma has become the major pathologic type of lung cancer.

会议

Lung cancerDriven genesMultidrug resistance

持续泵入恩度联合白蛋白紫杉醇及奈达铂方案治疗晚期鳞癌的近期疗效观察

目的：观察持续泵入恩度联合白蛋白紫杉醇及奈达铂方案治疗晚期鳞癌的疗效及毒副反应。方法：经病理组织学或细胞学证实的22例晚期鳞癌患者,采用持续泵入恩度3mg/d持续泵入,第1-7天,白蛋白紫杉醇200mg/m2,第一天。

会议

持续泵入恩度

Quality of life and fatigue in cancer patients in Taiwan: Differences by age

Objective: Patient with different age could affect the ability to manage the symptom distress and their level of quality of life (QOL).Furthermore, cancer-related fatigue (CRF) is the most experienced

会议

quality of lifecancer-related fatiguesymptom dis

不同年龄女性乳腺癌临床病理特征分析

目的：研究不同年龄段乳腺癌的临床病理资料，评估国人不同年龄段患者的临床病理特征、免疫组化表达情况及临床分子分型的差异，对比分析不同年龄乳腺癌的生物学特征，研究乳腺癌的好发人群以便于进行重点防治和筛查，以及临床评估乳腺癌的进展、预后、指导临床治疗。

会议

乳腺癌年龄免疫组化

依西美坦+依维莫司治疗乳腺癌并发酮症酸中毒急性胰腺炎及脑出血一例

与本文相关的学术论文